Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03271983 · ClinicalTrials.gov registry record · Early Phase 1
Pharmacokinetics of Metronidazole Dermal Products
A Early Phase 1 study, sponsored by University of Maryland, Baltimore.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 7
- Enrollment target
NCT03271983: Completed Early Phase 1 study, sponsored by University of Maryland, Baltimore.
NCT03271983 is a Early Phase 1 study that has completed, run by University of Maryland, Baltimore. The registered enrollment target is 7 participants, below the 53-participant average among 2,764 other Early Phase 1 trials with a reported enrollment target (87% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03271983, a Early Phase 1 study, has completed, sponsored by University of Maryland, Baltimore.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 7 participants
- Enrollment target
Study Summary
Generate human PK data by collecting data following the application of metronidazole formulations.
Primary Outcome
Area under the concentration-time curve from 0 to 25 h
Interventions
- DRUG Metronidazole gel 1
- DRUG Metronidazole gel 2
- DRUG Metronidazole cream
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7 participants |
| Start Date | 2019-04-09 |
| Est. Completion | 2019-11-03 |
| Phase | Early Phase 1 |
What the finished NCT03271983 record still lists
NCT03271983 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 7 participants, a relatively small participant target, below the 53-participant average among 2,764 other Early Phase 1 trials with a reported enrollment target (87% lower).
The record links to 0 conditions, and to 3 interventions - of which Metronidazole gel 1 is the first listed.
NCT03271983 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03271983 about?
NCT03271983 is a clinical study titled "Pharmacokinetics of Metronidazole Dermal Products". Generate human PK data by collecting data following the application of metronidazole formulations.
What is the current status of trial NCT03271983?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 7 participants. The study started on 2019-04-09. Estimated completion is 2019-11-03.
What interventions are being tested in trial NCT03271983?
The interventions under investigation include: Metronidazole gel 1 (DRUG), Metronidazole gel 2 (DRUG), Metronidazole cream (DRUG).
Who is sponsoring clinical trial NCT03271983?
This trial is sponsored by University of Maryland, Baltimore, which has 560 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03271983's enrollment target sits among peer trials
7 1826th of 2000 higher than 156 of 2,000 other Early Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Early Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI